Rx (Prescription Medicine)
USD $ 120.00
Nanopacli 100mg 注射液是一种重要的药物，用于治疗多种癌症。其活性成分帕克塞尔（Paclitaxel）是一种强效化疗药物，属于紫杉醇类。帕克塞尔通过干扰微管的正常分解来发挥作用，微管是细胞分裂的关键组成部分。通过破坏这一过程，Nanopacli 有效抑制快速分裂癌细胞的增殖，从而导致肿瘤缩小并得到控制。
该注射液主要用于治疗转移性乳腺癌、卵巢癌和非小细胞肺癌。它也可能用于其他特定的肿瘤学适应症，具体取决于医疗专业人员的判断。
Nanopacli 100mg 注射液的剂量和用法严格由主治医生根据癌症的类型和阶段以及患者的整体健康状况确定。通常通过静脉给药。
与Nanopacli相关的常见不良反应包括骨髓抑制（导致血细胞计数下降）、周围神经病变（手脚麻木、刺痛或疼痛）、脱发、恶心、呕吐和过敏反应。患者应立即向医生报告任何不寻常或严重的不良反应。
Nanopacli 100mg 注射液应储存在室温，避免光照，且不应冷冻。务必遵循制造商和医疗提供者提供的所有储存说明。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Pack Quantity | |
| Strength |
其他品牌的 Paclitaxel 100 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
